Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 815CNS 115Thoracic 95Sarcoma 79Other solid neoplasm 75Tumor-Agnostic 40Breast 34Gynecologic 23Genitourinary 21Lymphoid 13Dermatologic 10Other hematologic neoplasm 9Head & Neck 9Endocrine 9NET 3Plasma cell 1Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1

Interventions

Dexamethasone 870Lenalidomide 456Bortezomib 454Cyclophosphamide 365Melphalan 271Calcium Dobesilate 262daratumumab 233pomalidomide 207carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74Cyclosporine 68isatuximab 67auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 56Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Irinotecan × Plasma cell × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡